Format

Send to:

Choose Destination
See comment in PubMed Commons below
Drugs Aging. 2012 Apr 1;29(4):329-34. doi: 10.2165/11207810-000000000-00000.

Bazedoxifene: a guide to its use in postmenopausal osteoporosis.

Author information

  • 1Adis, Auckland, New Zealand.

Abstract

Oral bazedoxifene (Conbriza®) reduces the incidence of new vertebral fractures in patients with postmenopausal osteoporosis. It also appears to reduce the risk of nonvertebral fractures in high-risk patients. Bazedoxifene is generally well tolerated and does not appear to have detrimental effects on endometrial or breast tissue.

PMID:
22462631
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk